Contineum Therapeutics (CTNM) Other Non Operating Income (2023 - 2026)
Contineum Therapeutics (CTNM) posted quarterly Other Non Operating Income of -$68000.0 for Q2 2026, up 59.28% year-over-year from -$42691.7 in Q2 2025, and down 19.3% quarter-over-quarter from -$57000.0 in Q1 2026.
Powered by 
Analysis
Contineum Therapeutics (CTNM) Other Non Operating Income (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$68000.0 for Q2 2026.
- In Q2 2026, Other Non Operating Income rose 59.28% year-over-year to -$68000.0; the TTM figure through Jun 2026 stood at $7000.0 (up 101.85% YoY), while the FY2025 annual figure was -$165000.0, down 1.23% from the prior year.
- Other Non Operating Income for Q2 2026 stood at -$68000.0, down from -$57000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $1.3 million in Q4 2023, with the low at -$167000.0 in Q2 2025.
- The 4-year median for Other Non Operating Income is -$49000.0 (2024), against an average of $49000.0.
- Peak annual rise in Other Non Operating Income reached 638.24% in 2025, while the deepest fall reached 2066.67% in 2025.
- Contineum Therapeutics' Other Non Operating Income stood at $1.3 million in 2023, then slumped by 103.7% to -$47000.0 in 2024, then slipped by 8.51% to -$51000.0 in 2025, then plunged by 33.33% to -$68000.0 in 2026.
- Business Quant data shows CTNM's Other Non Operating Income at -$68000.0 in Q2 2026, -$57000.0 in Q1 2026, and -$51000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Contineum Therapeutics | 621.59 Mn | 621.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -68,000.00 |
| Mar 31, 2026 | -57,000.00 |
| Dec 31, 2025 | -51,000.00 |
| Sep 30, 2025 | 183,000.00 |
| Jun 30, 2025 | -167,000.00 |
| Mar 31, 2025 | -130,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Sep 30, 2024 | -34,000.00 |
| Jun 30, 2024 | -77,000.00 |
| Mar 31, 2024 | -6,000.00 |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | -36,000.00 |
| Jun 30, 2023 | -76,000.00 |
| Mar 31, 2023 | -18,000.00 |